Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.
2.

WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP).

de la Fuente MA, Sasahara Y, Calamito M, Antón IM, Elkhal A, Gallego MD, Suresh K, Siminovitch K, Ochs HD, Anderson KC, Rosen FS, Geha RS, Ramesh N.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):926-31. Epub 2007 Jan 9.

3.

Microdebrider excision of a lipoma of the esophageal inlet.

Rosen FS, Newlands SD.

Otolaryngol Head Neck Surg. 2005 Sep;133(3):450-2. No abstract available.

PMID:
16143199
4.

Genotype-proteotype linkage in the Wiskott-Aldrich syndrome.

Lutskiy MI, Rosen FS, Remold-O'Donnell E.

J Immunol. 2005 Jul 15;175(2):1329-36.

5.

Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.

Lutskiy MI, Beardsley DS, Rosen FS, Remold-O'Donnell E.

Blood. 2005 Oct 15;106(8):2815-7. Epub 2005 Jun 28.

6.

Prolonged infusion of dexmedetomidine for sedation following tracheal resection.

Hammer GB, Philip BM, Schroeder AR, Rosen FS, Koltai PJ.

Paediatr Anaesth. 2005 Jul;15(7):616-20.

PMID:
15960649
7.

Deficiencies of C1 inhibitor.

Rosen FS, Davis AE 3rd.

Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):251-61. Review.

PMID:
15833691
8.

WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo.

Snapper SB, Meelu P, Nguyen D, Stockton BM, Bozza P, Alt FW, Rosen FS, von Andrian UH, Klein C.

J Leukoc Biol. 2005 Jun;77(6):993-8. Epub 2005 Mar 17.

PMID:
15774550
9.

Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome.

Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O'Donnell E.

Clin Exp Immunol. 2005 Feb;139(2):297-305. Erratum in: Clin Exp Immunol. 2005 May;140(2):394.

10.

Isolation of poliovirus--John Enders and the Nobel Prize.

Rosen FS.

N Engl J Med. 2004 Oct 7;351(15):1481-3. No abstract available.

PMID:
15470207
11.

Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.

Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O'Donnell E.

Clin Exp Immunol. 2004 Apr;136(1):104-10. Erratum in: Clin Exp Immunol. 2004 Jul;137(1):223.

12.

Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.

Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W.

J Exp Med. 2003 Nov 17;198(10):1595-608.

13.
14.

WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility.

Yan C, Martinez-Quiles N, Eden S, Shibata T, Takeshima F, Shinkura R, Fujiwara Y, Bronson R, Snapper SB, Kirschner MW, Geha R, Rosen FS, Alt FW.

EMBO J. 2003 Jul 15;22(14):3602-12.

15.

High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients.

Shcherbina A, Candotti F, Rosen FS, Remold-O'Donnell E.

Br J Haematol. 2003 May;121(3):529-30. Review. No abstract available.

PMID:
12716381
16.

A family of WASPs.

Snapper SB, Rosen FS.

N Engl J Med. 2003 Jan 23;348(4):350-1. Review. No abstract available.

PMID:
12540651
17.

Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.

Klein C, Nguyen D, Liu CH, Mizoguchi A, Bhan AK, Miki H, Takenawa T, Rosen FS, Alt FW, Mulligan RC, Snapper SB.

Blood. 2003 Mar 15;101(6):2159-66. Epub 2002 Nov 14.

18.

A novel protocol to identify mutations in patients with wiskott-Aldrich syndrome.

Jones LN, Lutskiy MI, Cooley J, Kenney DM, Rosen FS, Remold-O'Donnell E.

Blood Cells Mol Dis. 2002 May-Jun;28(3):392-8.

PMID:
12367583
19.

Wiskott-Aldrich syndrome in a female.

Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O'Donnell E.

Blood. 2002 Oct 15;100(8):2763-8.

20.

Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.

Orange JS, Ramesh N, Remold-O'Donnell E, Sasahara Y, Koopman L, Byrne M, Bonilla FA, Rosen FS, Geha RS, Strominger JL.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11351-6. Epub 2002 Aug 12.

21.

Obstructive supraglottic schwannoma: a case report and review of the literature.

Rosen FS, Pou AM, Quinn FB Jr.

Laryngoscope. 2002 Jun;112(6):997-1002. Review.

PMID:
12160298
22.

An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndrome.

Lutskiy MI, Jones LN, Rosen FS, Remold-O'Donnell E.

Hum Genet. 2002 May;110(5):515-9. Epub 2002 Apr 10.

PMID:
12073025
23.

Successful gene therapy for severe combined immunodeficiency.

Rosen FS.

N Engl J Med. 2002 Apr 18;346(16):1241-3. No abstract available.

PMID:
11961154
24.

The immunology series comes to an end.

Rosen FS, Mackay I.

N Engl J Med. 2001 Nov 1;345(18):1343-4. No abstract available.

PMID:
11794157
25.

WASP and N-WASP in human platelets differ in sensitivity to protease calpain.

Shcherbina A, Miki H, Kenney DM, Rosen FS, Takenawa T, Remold-O'Donnell E.

Blood. 2001 Nov 15;98(10):2988-91.

26.

N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility.

Snapper SB, Takeshima F, Antón I, Liu CH, Thomas SM, Nguyen D, Dudley D, Fraser H, Purich D, Lopez-Ilasaca M, Klein C, Davidson L, Bronson R, Mulligan RC, Southwick F, Geha R, Goldberg MB, Rosen FS, Hartwig JH, Alt FW.

Nat Cell Biol. 2001 Oct;3(10):897-904.

PMID:
11584271
27.

A brief history of immunodeficiency disease.

Rosen FS.

Immunol Rev. 2000 Dec;178:8-12. No abstract available.

PMID:
11213810
28.

Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability.

Chen F, Ma L, Parrini MC, Mao X, Lopez M, Wu C, Marks PW, Davidson L, Kwiatkowski DJ, Kirchhausen T, Orkin SH, Rosen FS, Mayer BJ, Kirschner MW, Alt FW.

Curr Biol. 2000 Jun 29;10(13):758-65.

29.

Reply To matzdorff, kemkes-matthes and pralle

Shcherbina A, Rosen FS, Remold-O'Donnell E.

Br J Haematol. 2000 Jun;109(3):674. No abstract available.

PMID:
10886227
30.

WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.

Shcherbina A, Rosen FS, Remold-O'Donnell E.

J Immunol. 1999 Dec 1;163(11):6314-20.

31.

Endoscopic surgical management of sphenoid sinus disease.

Rosen FS, Sinha UK, Rice DH.

Laryngoscope. 1999 Oct;109(10):1601-6.

PMID:
10522928
32.

Pathological events in platelets of Wiskott-Aldrich syndrome patients.

Shcherbina A, Rosen FS, Remold-O'Donnell E.

Br J Haematol. 1999 Sep;106(4):875-83.

PMID:
10519987
33.

The cytoskeletal linker protein moesin: decreased levels in Wiskott-Aldrich syndrome platelets and identification of a cleavage pathway in normal platelets.

Shcherbina A, Bretscher A, Rosen FS, Kenney DM, Remold-O'Donnell E.

Br J Haematol. 1999 Jul;106(1):216-23. Erratum in: Br J Haematol 1999 Oct;107(1):218.

PMID:
10444190
34.

The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.

Snapper SB, Rosen FS.

Annu Rev Immunol. 1999;17:905-29. Review.

PMID:
10358777
35.

Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.

Snapper SB, Rosen FS, Mizoguchi E, Cohen P, Khan W, Liu CH, Hagemann TL, Kwan SP, Ferrini R, Davidson L, Bhan AK, Alt FW.

Immunity. 1998 Jul;9(1):81-91.

36.

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.

Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP.

Transfusion. 1998 Jun;38(6):540-9.

PMID:
9661687
37.

Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.

Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD Jr, Rosen FS, Carroll MC.

J Immunol. 1997 Jul 15;159(2):976-82.

PMID:
9218619
38.

Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide.

Reid RR, Prodeus AP, Khan W, Hsu T, Rosen FS, Carroll MC.

J Immunol. 1997 Jul 15;159(2):970-5.

PMID:
9218618
39.

Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.

Remold-O'Donnell E, Cooley J, Shcherbina A, Hagemann TL, Kwan SP, Kenney DM, Rosen FS.

J Immunol. 1997 May 1;158(9):4021-5.

PMID:
9126958
40.

Molecular defects in hereditary angioneurotic edema.

Bissler JJ, Aulak KS, Donaldson VH, Rosen FS, Cicardi M, Harrison RA, Davis AE 3rd.

Proc Assoc Am Physicians. 1997 Mar;109(2):164-73.

PMID:
9069585
41.

Severe combined immunodeficiency: a pediatric emergency.

Rosen FS.

J Pediatr. 1997 Mar;130(3):345-6. No abstract available.

PMID:
9063405
42.

Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome.

Gerwin N, Friedrich C, Perez-Atayde A, Rosen FS, Gutierrez-Ramos JC.

Clin Exp Immunol. 1996 Nov;106(2):208-17.

43.

Regulation of the B cell response to T-dependent antigens by classical pathway complement.

Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC.

J Immunol. 1996 Jul 15;157(2):549-56.

PMID:
8752901
44.

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.

Waytes AT, Rosen FS, Frank MM.

N Engl J Med. 1996 Jun 20;334(25):1630-4.

45.

Disease mechanism: unravelling Wiskott-Aldrich syndrome.

Kirchhausen T, Rosen FS.

Curr Biol. 1996 Jun 1;6(6):676-8. Review.

46.

The enigma of the Wiskott-Aldrich syndrome begins to unravel.

Rosen FS.

J Clin Invest. 1996 Jun 1;97(11):2407. No abstract available.

47.

Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.

Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5615-8.

48.

Defects in Wiskott-Aldrich syndrome blood cells.

Remold-O'Donnell E, Rosen FS, Kenney DM.

Blood. 1996 Apr 1;87(7):2621-31. Review. No abstract available.

49.
50.

The role of Bruton's tyrosine kinase in B-cell development and function in mice and man.

Khan WN, Sideras P, Rosen FS, Alt FW.

Ann N Y Acad Sci. 1995 Sep 29;764:27-38. Review. No abstract available.

PMID:
7486535

Supplemental Content

Loading ...
Support Center